Committee Opinion No. 691: Carrier Screening for Genetic Conditions
- PMID: 28225426
- DOI: 10.1097/AOG.0000000000001952
Committee Opinion No. 691: Carrier Screening for Genetic Conditions
Abstract
Carrier screening is a term used to describe genetic testing that is performed on an individual who does not have any overt phenotype for a genetic disorder but may have one variant allele within a gene(s) associated with a diagnosis. Information about carrier screening should be provided to every pregnant woman. Carrier screening and counseling ideally should be performed before pregnancy because this enables couples to learn about their reproductive risk and consider the most complete range of reproductive options. A patient may decline any or all screening. When an individual is found to be a carrier for a genetic condition, his or her relatives are at risk of carrying the same mutation. The patient should be encouraged to inform his or her relatives of the risk and the availability of carrier screening. If an individual is found to be a carrier for a specific condition, the patient's reproductive partner should be offered testing in order to receive informed genetic counseling about potential reproductive outcomes. If both partners are found to be carriers of a genetic condition, genetic counseling should be offered. What follows is a detailed discussion of some of the more common genetic conditions for which carrier screening is recommended in at least some segments of the population.
References
-
- Family history as a risk assessment tool. Committee Opinion No. 478. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011;117:747–50.
-
- Hereditary cancer syndromes and risk assessment. Committee Opinion No. 634. American College of Obste-tricians and Gynecologists. Obstet Gynecol 2015;125: 1538–43.
-
- Prior TW. Carrier screening for spinal muscular atrophy. Professional Practice and Guidelines Committee. Genet Med 2008;10:840–2.
-
- Prior TW, Snyder PJ, Rink BD, Pearl DK, Pyatt RE, Mihal DC, et al. Newborn and carrier screening for spinal muscular atrophy. Am J Med Genet A 2010;152A:1608–16.
-
- Mailman MD, Heinz JW, Papp AC, Snyder PJ, Sedra MS, Wirth B, et al. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med 2002;4:20–6.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical